Syneron Medical Company Profile (NASDAQ:ELOS)

About Syneron Medical (NASDAQ:ELOS)

Syneron Medical logoSyneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company's aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company's products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Symbol: NASDAQ:ELOS
  • CUSIP: N/A
  • Web:
Average Prices:
  • 50 Day Moving Avg: $10.90
  • 200 Day Moving Avg: $10.14
  • 52 Week Range: $6.18 - $11.43
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 21.15
  • P/E Growth: 0.00
  • Net Margins: -1.09%
  • Return on Equity: -1.74%
  • Return on Assets: -1.30%
  • Current Ratio: 2.68%
  • Quick Ratio: 1.84%
  • Average Volume: 797,289 shs.
  • Beta: 1.25

Frequently Asked Questions for Syneron Medical (NASDAQ:ELOS)

What is Syneron Medical's stock symbol?

Syneron Medical trades on the NASDAQ under the ticker symbol "ELOS."

How were Syneron Medical's earnings last quarter?

Syneron Medical Ltd. (NASDAQ:ELOS) posted its earnings results on Thursday, August, 4th. The company reported $0.09 earnings per share for the quarter, topping analysts' consensus estimates of $0.06 by $0.03. The firm had revenue of $75 million for the quarter, compared to the consensus estimate of $75.72 million. Syneron Medical had a negative return on equity of 1.74% and a negative net margin of 1.09%. The business's revenue for the quarter was up 2.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.07 EPS. View Syneron Medical's Earnings History.

Where is Syneron Medical's stock going? Where will Syneron Medical's stock price be in 2017?

2 brokers have issued 12-month price targets for Syneron Medical's shares. Their predictions range from $11.00 to $11.00. On average, they expect Syneron Medical's share price to reach $11.00 in the next twelve months. View Analyst Ratings for Syneron Medical.

What are analysts saying about Syneron Medical stock?

Here are some recent quotes from research analysts about Syneron Medical stock:

  • 1. Maxim Group analysts commented, "On May 10, 2017, ELOS announced the expiration of the go-shop" period under its merger agreement with Apax Partners. During the go-shop period, ELOS engaged in an active and extensive solicitation of 59 potential bidders, which resulted in two potential bidders each negotiating and entering into a confidentiality agreement. However, they subsequently confirmed that they weren’t interested in pursuing an acquisition of ELOS. The acquisition by Apax Partners is expected to be completed during 3Q17, subject to ELOS shareholder approval and the satisfaction of other customary closing conditions." (5/12/2017)
  • 2. According to Zacks Investment Research, "Syneron Medical Ltd. manufactures and distributes medical aesthetic devices that are powered by the proprietary, patented ELOS combined-energy technology of Bi-Polar Radio Frequency and Light. The Company's innovative ELOS technology provides the foundation for highly effective, safe and cost-effective systems that enable physicians to provide advanced solutions for a broad range of medical-aesthetic applications. " (1/11/2017)

Who are some of Syneron Medical's key competitors?

Who are Syneron Medical's key executives?

Syneron Medical's management team includes the folowing people:

  • Shimon Eckhouse Ph.D., Chairman of the Board
  • Amit Meridor, Chief Executive Officer
  • Hugo Goldman, Chief Financial Officer
  • Erik Dowell, Vice President-North America
  • William Griffing, Chief Executive Officer - Syneron Candela North America
  • Shlomo Alkalay, Chief Operating Officer
  • Lisa A. Soderquist, Chief Human Resource Officer
  • Robert Ruck, Executive Vice President, Asia Pacific
  • Robert Fielitz, Vice President and Managing Director of Europe, Middle East and Africa
  • Sarit Soccary Ben-Yochanan, Vice President - Business Development & Strategy

Who owns Syneron Medical stock?

Syneron Medical's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Brandes Investment Partners LP (0.00%), BRANDES INVESTMENT PARTNERS, LP (9.87%), CNH Partners LLC (0.00%), K2 Principal Fund L.P. (0.00%), Vivaldi Asset Management LLC (0.00%) and Dalton Greiner Hartman Maher & Co. (2.52%). View Institutional Ownership Trends for Syneron Medical.

Who sold Syneron Medical stock? Who is selling Syneron Medical stock?

Syneron Medical's stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Brandes Investment Partners LP, Lapides Asset Management LLC, Ameriprise Financial Inc., Profit Investment Management LLC, QS Investors LLC, Eagle Global Advisors LLC and California Public Employees Retirement System. View Insider Buying and Selling for Syneron Medical.

Who bought Syneron Medical stock? Who is buying Syneron Medical stock?

Syneron Medical's stock was bought by a variety of institutional investors in the last quarter, including CNH Partners LLC, K2 Principal Fund L.P., Vivaldi Asset Management LLC, SG Americas Securities LLC, Commonwealth of Pennsylvania Public School Empls Retrmt SYS, Mizuho Securities USA LLC, City Financial Investment Co Ltd and Virtu KCG Holdings LLC. View Insider Buying and Selling for Syneron Medical.

How do I buy Syneron Medical stock?

Shares of Syneron Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Syneron Medical's stock price today?

One share of Syneron Medical stock can currently be purchased for approximately $11.00.

MarketBeat Community Rating for Syneron Medical (NASDAQ ELOS)
Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  130 (Vote Outperform)
Underperform Votes:  74 (Vote Underperform)
Total Votes:  204
MarketBeat's community ratings are surveys of what our community members think about Syneron Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Syneron Medical (NASDAQ:ELOS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $11.00 (0.00% downside)

Analysts' Ratings History for Syneron Medical (NASDAQ:ELOS)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/12/2017Maxim GroupDowngradeBuy -> Hold$12.00 -> $11.00MediumView Rating Details
10/24/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
8/5/2016Leerink SwannDowngradeOutperform -> Market Perform$9.40 -> $7.80N/AView Rating Details
(Data available from 9/20/2015 forward)


Earnings History for Syneron Medical (NASDAQ:ELOS)
Earnings by Quarter for Syneron Medical (NASDAQ:ELOS)
Earnings History by Quarter for Syneron Medical (NASDAQ ELOS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/15/2017Q416$0.03($0.03)$82.02 million$82.90 millionViewListenView Earnings Details
11/9/2016Q316($0.02)$0.02$68.08 million$71.50 millionViewListenView Earnings Details
8/4/2016Q216$0.06$0.09$75.72 million$75.00 millionViewListenView Earnings Details
5/19/2016Q116$0.01$0.04$64.38 million$68.70 millionViewListenView Earnings Details
2/22/2016Q415$0.07$0.07$75.56 million$78.90 millionViewListenView Earnings Details
11/11/2015Q315$0.03$0.03$66.60 million$62.10 millionViewListenView Earnings Details
8/4/2015Q215$0.06$0.04$70.93 million$73.50 millionViewN/AView Earnings Details
5/13/2015Q115$0.01$0.02$62.08 million$63.40 millionViewListenView Earnings Details
2/18/2015Q414$0.06$0.09$71.42 million$74.10 millionViewN/AView Earnings Details
11/12/2014Q314$0.03$0.03$58.32 million$60.30 millionViewN/AView Earnings Details
8/6/2014Q214$0.07$0.07$63.52 million$64.60 millionViewListenView Earnings Details
5/14/2014Q114$0.04$0.04$55.50 million$56.80 millionViewN/AView Earnings Details
2/20/2014Q413$0.08$0.11$65.70 million$64.30 millionViewListenView Earnings Details
11/13/2013Q313$0.01$0.04$62.06 million$62.70 millionViewListenView Earnings Details
8/14/2013Q2 2013$0.09$0.02$70.93 million$68.80 millionViewN/AView Earnings Details
5/22/2013Q1 2013$0.02$0.02$61.19 million$61.20 millionViewN/AView Earnings Details
2/12/2013Q4 2012$0.09$0.11$70.60 million$72.80 millionViewN/AView Earnings Details
11/7/2012Q312$0.04$0.03$65.51 million$60.13 millionViewN/AView Earnings Details
8/15/2012$0.04$0.05ViewN/AView Earnings Details
2/9/2012$0.04$0.03ViewN/AView Earnings Details
11/10/2011($0.09)($0.03)ViewN/AView Earnings Details
8/11/2011($0.02)($0.01)ViewN/AView Earnings Details
5/19/2011($0.04)$0.01ViewN/AView Earnings Details
2/16/2011($0.04)$0.24ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Syneron Medical (NASDAQ:ELOS)
Current Year EPS Consensus Estimate: $0.33 EPS
Next Year EPS Consensus Estimate: $0.52 EPS


Dividend History for Syneron Medical (NASDAQ:ELOS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Syneron Medical (NASDAQ:ELOS)
No insider trades for this company have been tracked by


Headline Trends for Syneron Medical (NASDAQ:ELOS)
Latest Headlines for Syneron Medical (NASDAQ:ELOS)
DateHeadline logoIntersect ENT (XENT) versus Syneron Medical (ELOS) Head to Head Comparison - September 19 at 2:30 PM logoComparing Syneron Medical (ELOS) & Align Technology (ALGN) - July 27 at 9:10 AM logoSyneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private Company - July 17 at 11:14 AM logoMedtech Mergers Surge Again - July 10 at 11:12 PM logoETFs with exposure to Syneron Medical Ltd. : July 10, 2017 - July 10 at 6:07 PM logoSyneron Medical Ltd. breached its 50 day moving average in a Bearish Manner : ELOS-US : July 7, 2017 - July 8 at 10:29 AM logoSyneron Medical Ltd. (NASDAQ:ELOS) Downgraded by BidaskClub - July 7 at 12:38 AM logoSyneron Medical Ltd. breached its 50 day moving average in a Bearish Manner : ELOS-US : June 21, 2017 - June 21 at 6:30 PM logoETFs with exposure to Syneron Medical Ltd. : June 19, 2017 - June 19 at 6:36 PM logoSyneron Medical Ltd. :ELOS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 - June 16 at 5:49 PM logoSyneron Candela Announces Shareholder Approval of Proposed Acquisition by Funds Advised by Apax Partners - June 15 at 7:00 PM logoSyneron Medical Ltd. (ELOS) Short Interest Up 6.3% in May - June 11 at 7:28 AM logoSyneron Medical Ltd. breached its 50 day moving average in a Bearish Manner : ELOS-US : May 29, 2017 - May 29 at 10:58 AM logoSyneron Medical Ltd. – Value Analysis (NASDAQ:ELOS) : May 18, 2017 - May 18 at 5:28 PM logoSyneron Medical Reports First Quarter 2017 Revenue of $66.9 Million - May 17 at 9:59 PM logoSyneron Medical reports 1Q loss - May 17 at 9:59 PM logoSyneron Medical Ltd. breached its 50 day moving average in a Bearish Manner : ELOS-US : May 17, 2017 - May 17 at 10:59 AM logoSyneron Medical Ltd. (ELOS) Cut to "Hold" at Maxim Group - May 12 at 8:20 AM logoSyneron Candela (ELOS) Announces Expiration of Go-Shop Period - May 10 at 5:06 PM logoSyneron Candela Announces End of Go-Shop Period - May 10 at 7:26 AM logoSyneron Medical (ELOS) Given Media Sentiment Rating of 0.14 - May 3 at 1:26 PM logoSyneron Medical (ELOS) Receives News Sentiment Score of 0.56 - April 29 at 9:43 AM logoSyneron Medical (ELOS) Earns Coverage Optimism Score of 0.14 - April 24 at 3:40 PM logoSyneron Medical (ELOS) Receives News Impact Score of 0.10 - April 20 at 5:00 PM logoSyneron Medical (ELOS) Getting Very Positive Press Coverage, Analysis Shows - April 15 at 8:26 AM logoApax to buy Israeli aesthetic device firm Syneron for $397 mln - April 3 at 10:17 PM logoApax to buy Israeli aesthetic device firm Syneron for $397 million - April 3 at 10:17 PM logoSyneron Medical (ELOS) Jumps on Apax Deal - April 3 at 5:16 PM logoSyneron Medical Agrees To Be Bought By Apax Partners For $397 Mln - Quick Facts - April 3 at 5:16 PM logoSyneron Medical Ltd. stock rises after nearly $400 mln acquisition of outstanding shares - April 3 at 5:16 PM logoApax eyes IPO for investment house Psagot in Tel Aviv -source - April 3 at 7:18 AM logoSyneron Candela Announces Agreement to be Acquired by Funds advised by Apax Partners for $11.00/share in Cash, Representing an Approximate Value of $397 Million - April 3 at 7:18 AM logoApax close to $500 mln deal to buy Israel's Syneron - reports - April 2 at 8:31 AM logoSYNERON MEDICAL LTD. Financials - March 29 at 5:28 PM logoForm 6-K Syneron Medical Ltd. For: Mar 27 - - March 28 at 9:40 PM logoSyneron Candela Announces CE Mark for CO2RE® Intima - March 27 at 11:59 AM logoSyneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F through its Website - March 23 at 5:28 PM logoSyneron Candela Announces New Technology and Indications at the 2017 American Academy of Dermatology (AAD) Annual Meeting - March 1 at 4:39 PM logoSyneron Medical: Still Frustrating - And Still Tantalizing - Seeking Alpha - February 24 at 5:43 PM logoSyneron Medical 4Q Loss 3 Cents a Share (ELOS) - February 16 at 4:40 PM logoSyneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million - February 16 at 4:40 PM logo7:02 am Syneron Medical beats by $0.05, beats on revs - February 16 at 4:40 PM logoQ4 2016 Syneron Medical Ltd Earnings Release - Before Market Open - February 16 at 4:40 PM logoSyneron Medical Reports 4Q Loss of 3 Cents a Share - February 16 at 4:40 PM logoEdited Transcript of ELOS earnings conference call or presentation 15-Feb-17 1:30pm GMT - February 16 at 7:42 AM logoUPDATE 2-Hologic buys Cynosure to expand into medical aesthetics - Nasdaq - February 14 at 5:51 PM logoSyneron Medical to Participate in Leerink Partners 6th Annual Global Healthcare Conference - February 13 at 5:42 PM logoApax Partners in talks to buy Israel's Syneron Medical -report - February 13 at 7:43 AM logoSientra (SIEN) Names Philippe Schaison to Board of Directors - February 7 at 6:06 PM logoSientra Appoints Aesthetic Industry Leader Philippe A. Schaison to Board of Directors - February 7 at 6:06 PM



Syneron Medical (ELOS) Chart for Wednesday, September, 20, 2017

This page was last updated on 9/20/2017 by Staff